This January 31, 2017 JAMA Viewpoint article examines whether Hemoglobin A1c should be used as an outcome (quality) measure Type 2 diabetes and its complications are one of the most expensive issues facing U.S. healthcare.  An obvious goal is to reduce the number  and scope of diabetic complications which should in return improve diabetic’s quality and likely longevity.  The… Read More